Bob C. Lin

8.6k total citations
16 papers, 239 citations indexed

About

Bob C. Lin is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Bob C. Lin has authored 16 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Bob C. Lin's work include HIV Research and Treatment (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Bob C. Lin is often cited by papers focused on HIV Research and Treatment (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Bob C. Lin collaborates with scholars based in United States, South Africa and Netherlands. Bob C. Lin's co-authors include Kaitlyn M. Morabito, Nicole A. Doria‐Rose, Barney S. Graham, Mark K. Louder, Peter D. Kwong, Baoshan Zhang, John R. Mascola, Krisha McKee, Awa Traoré and Fadima Cheick Haidara and has published in prestigious journals such as Nature Communications, Immunity and Clinical Infectious Diseases.

In The Last Decade

Bob C. Lin

15 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bob C. Lin United States	8	88	76	74	71	61	16	239
Paola Martinez-Murillo United States	7	75 0.9×	33 0.4×	101 1.4×	52 0.7×	28 0.5×	11	215
Abigail E. Schiff United States	8	38 0.4×	59 0.8×	127 1.7×	40 0.6×	11 0.2×	11	210
Glenda Canderan United States	9	64 0.7×	34 0.4×	78 1.1×	42 0.6×	14 0.2×	16	219
Samuel Lebourgeois France	7	20 0.2×	65 0.9×	200 2.7×	48 0.7×	22 0.4×	11	257
H.-G. Kraeusslich Germany	3	94 1.1×	32 0.4×	254 3.4×	83 1.2×	13 0.2×	3	338
Edith E. Schermer United States	7	103 1.2×	29 0.4×	33 0.4×	65 0.9×	39 0.6×	8	184
Farbod Alinezhad Iran	7	24 0.3×	24 0.3×	58 0.8×	32 0.5×	13 0.2×	13	167
Marloes Grobben Netherlands	8	37 0.4×	27 0.4×	66 0.9×	21 0.3×	38 0.6×	18	135
Alex Farina Switzerland	5	16 0.2×	40 0.5×	193 2.6×	42 0.6×	14 0.2×	7	338

Countries citing papers authored by Bob C. Lin

Since Specialization

Citations

This map shows the geographic impact of Bob C. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob C. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob C. Lin more than expected).

Fields of papers citing papers by Bob C. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob C. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob C. Lin. The network helps show where Bob C. Lin may publish in the future.

Co-authorship network of co-authors of Bob C. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Bob C. Lin. A scholar is included among the top collaborators of Bob C. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob C. Lin. Bob C. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mason, Rosemarie D., Baoshan Zhang, Nicholas C. Morano, et al.. (2025). Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage. Cell Reports. 44(1). 115223–115223.

Holt, Graham T., Jason Gorman, Siyu Wang, et al.. (2023). Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design. Cell Reports. 42(7). 112711–112711. 5 indexed citations

Enose‐Akahata, Yoshimi, Dima A. Hammoud, Sandeep Narpala, et al.. (2023). Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurology Neuroimmunology & Neuroinflammation. 10(4). 28 indexed citations

Kwon, Young Do, Amarendra Pegu, Eun Sung Yang, et al.. (2023). Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain. mAbs. 15(1). 2223350–2223350. 2 indexed citations

Zhou, Tongqing, Lei Chen, Jason Gorman, et al.. (2022). Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site. Structure. 30(6). 862–875.e4. 9 indexed citations

Chang, Lauren A., Emily Phung, Michelle C. Crank, et al.. (2022). A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine. Science Translational Medicine. 14(676). eade0424–eade0424. 27 indexed citations

Kwon, Young Do, Mangaiarkarasi Asokan, Jason Gorman, et al.. (2021). A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention. mAbs. 13(1). 1946918–1946918. 13 indexed citations

Lee, Myungjin, Anita Changela, Jason Gorman, et al.. (2021). Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces. Nature Communications. 12(1). 6470–6470. 3 indexed citations

Xia, Shi-Mao, Robert Parks, Haiyan Chen, et al.. (2021). Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations. Cell Reports. 36(7). 109561–109561. 4 indexed citations

10.

Chen, Xuejun, Tongqing Zhou, Stephen D. Schmidt, et al.. (2021). Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth. Immunity. 54(2). 324–339.e8. 23 indexed citations

11.

Chuang, Gwo-Yu, Mangaiarkarasi Asokan, Vera B. Ivleva, et al.. (2020). Removal of variable domain N -linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies. mAbs. 12(1). 1836719–1836719. 3 indexed citations

12.

Gorman, Jason, Gwo‐Yu Chuang, Yen‐Ting Lai, et al.. (2020). Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition. Cell Reports. 31(1). 107488–107488. 32 indexed citations

13.

Buchwald, Andrea G., Barney S. Graham, Awa Traoré, et al.. (2020). Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life. Clinical Infectious Diseases. 73(11). e4421–e4427. 47 indexed citations

14.

Li, Jerry, Mina Nikanjam, Coleen K. Cunningham, et al.. (2020). Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach. Clinical Pharmacology & Therapeutics. 109(1). 184–192. 3 indexed citations

15.

Gorman, Jason, Gwo‐Yu Chuang, Yen‐Ting Lai, et al.. (2019). Structure of Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition. SSRN Electronic Journal. 1 indexed citations

16.

Lai, Yen‐Ting, Tao Wang, Sijy O’Dell, et al.. (2018). Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry. Nature Communications. 10(1). 47–47. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact